Contributed

chemotherapy-448578_960_720

FDA Approves 2 New Female Hair Loss Treatments

The FDA has lifted its hold on the clinical trial testing of the drug CTP-543. The drug is currently being studied by Concert Pharmaceuticals Inc to treat alopecia areata. Alopecia areata is just